Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-01

Clinical Trial Update: Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis [Phase 3]

View source ↗

Summary

Phase 3 placebo-controlled study of GW685698X in pediatric perennial allergic rhinitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GW685698X

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial | Phase 3 | Status: COMPLETED | Results posted: 2013-05-01